Iron Deficiency as a Therapeutic Target in Cardiovascular Disease

Iron Deficiency as a Therapeutic Target in Cardiovascular Disease

Iron deficiency is the most common nutritional disorder in the world. It is prevalent amongst patients with cardiovascular disease, in whom it is associated with worse clinical outcomes. The benefits of iron supplementation have been established in chronic heart failure, but data on their effectiven...

Full description

Bibliographic Details
Main Author:	Samira Lakhal-Littleton
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Series:	Pharmaceuticals
Subjects:	iron hepcidin iron regulatory proteins cardiomyocyte chronic heart failure pulmonary arterial smooth muscle cells pulmonary arterial hypertension
Online Access:	https://www.mdpi.com/1424-8247/12/3/125

Similar Items

Pulmonary Arterial Hypertension: Iron Matters
by: Latha Ramakrishnan, et al.
Published: (2018-05-01)

Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
by: Marceau Quatredeniers, et al.
Published: (2021-02-01)

Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center
by: Tilea I, et al.
Published: (2021-07-01)

Cryoablation method for pulmonary artery sympathetic denervation in patients with pulmonary hypertension secondary to left sided heart disease: interventional technique, safety and results of the hospital phase
by: D. A. Feshchenko, et al.
Published: (2019-09-01)

MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3
by: Ying Xu, et al.
Published: (2017-08-01)

Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins
by: Manik C. Ghosh, et al.
Published: (2015-09-01)

Baicalin Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via the AKT/HIF-1α/p27-Associated Pathway
by: Lin Zhang, et al.
Published: (2014-05-01)

Multiprofessional and Intrahospital Experience for Diagnosis and Treatment of Pulmonary Arterial Hypertension
by: Michele Correale, et al.
Published: (2015-12-01)

Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
by: Liu P, et al.
Published: (2021-04-01)

Aloperine suppresses human pulmonary vascular smooth muscle cell proliferation via inhibiting inflammatory response
by: Zhi Chang, et al.
Published: (2019-01-01)

Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells
by: Yun Yue, et al.
Published: (2020-01-01)

The physiological functions of iron regulatory proteins in iron homeostasis - an update
by: De-Liang eZhang, et al.
Published: (2014-06-01)

An essential cell-autonomous role for hepcidin in cardiac iron homeostasis
by: Samira Lakhal-Littleton, et al.
Published: (2016-11-01)

Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
by: Speranza Rubattu, et al.
Published: (2019-08-01)

Iron Deficiency Anemia
by: Na Hee Lee
Published: (2020-10-01)

Etiopathenogenic bases for the development of pulmonary hypertension and chronic heart failure in patients with ischemic heart disease in combination with arterial hypertension (literature review, observation of the authors)
by: N. A. Matsegora, et al.
Published: (2017-06-01)

Echinacoside prevents hypoxic pulmonary hypertension by regulating the pulmonary artery function
by: Xiangyun Gai, et al.
Published: (2020-12-01)

Role of RASEF hypermethylation in cigarette smoke-induced pulmonary arterial smooth muscle remodeling
by: Qinghai Li, et al.
Published: (2019-03-01)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
by: Magdalena Dziegala, et al.
Published: (2018-10-01)

Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
by: Argen Mamazhakypov, et al.
Published: (2021-08-01)

Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease—First Report on the Prospective Relevance of Intrinsic Iron Release
by: Julia Ruhe, et al.
Published: (2018-08-01)

A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study
by: Hildenbrand Florian F, et al.
Published: (2012-09-01)

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous
by: Frédéric Perros, et al.
Published: (2019-07-01)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)

Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
by: Haihua Qiu, et al.
Published: (2021-03-01)

IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. I. Stuklov
Published: (2017-11-01)

ACQUIRED REFRACTORY IRON DEFICIENCY
by: Margherita Migone De Amicis, et al.
Published: (2021-04-01)

ACQUIRED REFRACTORY IRON DEFICIENCY
by: Margherita Migone De Amicis, et al.
Published: (2021-04-01)

MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension
by: Ying Li, et al.
Published: (2019-01-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
by: John J. Ryan, MD
Published: (2016-12-01)

Characterization and treatment challenges of pulmonary hypertension in methamphetamine users
by: Kathryn Hendrickson, et al.
Published: (2020-01-01)

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
by: L.S. Howard
Published: (2011-12-01)

Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway
by: Zengxian Sun, et al.
Published: (2017-08-01)

Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
by: Suiqing Huang, et al.
Published: (2020-05-01)

Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis
by: Li Yi, et al.
Published: (2021-07-01)

Iron deficiency and iron deficiency anaemia in elderly patients with chronic heart failure
by: Lorenzo Palleschi, et al.
Published: (2017-12-01)

The effect of nonsurgical periodontal therapy on hepcidin and on inflammatory and iron marker levels
by: Sandra Augusta de Moura LEITE, et al.

Evaluation of hepcidin as a biomarker for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease
by: Ephraim Chikwanda
Published: (2018-01-01)

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Ye. D. Bazdyrev, et al.
Published: (2014-11-01)

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Ye. D. Bazdyrev, et al.
Published: (2014-11-01)